Antimicrobial peptides (AMPs) are known to play important roles in the innate host defense mechanisms of most living organisms. Protease inhibitors from plants potently inhibit the growth of a variety of pathogenic bacteria and fungi. Therefore, there are excellent candidates for the development of novel antimicrobial agents. In this study, an antimicrobial peptide derived from tartary buckwheat seeds (FtAMP) was obtained by gene cloning, expression and purification, which exhibited inhibitory activity toward trypsin. Furthermore, the relationship between the antimicrobial and inhibitory activities of FtAMP was investigated. Two mutants (FtAMP-R21A and FtAMP-R21F) were generated through site-directed mutagenesis. Inhibitory activity analysis showed that both FtAMP-R21A and FtAMP-R21F lost trypsin-inhibitory activity. However, FtAMP-R21A and FtAMP-R21F showed novel inhibitory activities against elastase and α-chymotrypsin, respectively, suggesting that Arg-21 in the inhibitory site loop is specific for the inhibitory activity of FtAMP against trypsin. Antimicrobial assays showed that all three peptides exhibited strong antifungal activity against Trichoderma koningii, Rhizopus sp., and Fusarium oxysporum. These results showed that the changes in FtAMP inhibitory site have no effect on their antifungal properties.
Introduction
Current abuse of antibiotics has resulted in a detrimental scenario where traditional antibiotics gradually lose efficacy against many pathogens due to the rapid development of resistance in these microorganisms. There is an urgent demand for the development of novel antibiotic compounds that offer different treatment strategies. Antimicrobial peptides (AMPs) have been proposed as promising alternatives to conventional antibiotics due to their potency at low concentrations and decreased risk for antimicrobial resistance. AMPs are widely distributed in all living kingdoms and are a group of low molecular weight peptides/proteins with broad-spectrum antimicrobial activities [1, 2] . AMPs are a unique and diverse group of molecules, which are divided into several subgroups based on their amino acid composition and structure. They are generally between 12 and 50 amino acids, include two or more positively charged residues which were provided by arginine and lysine or in acidic environments by histidine, and a large proportion (generally >50%) of hydrophobic residues [3] .
Plant AMPs are ubiquitously found in nature and are fast-acting against microorganisms with a broad spectrum and low cytotoxicity to animals. Moreover, they do no harm to the environment [4] . Plant AMPs can act against fungi, bacteria, and enveloped viruses, inhibit insect hydrolases [5] , and possess anti-viral, anti-tumor, antiinflammatory, healing, and immunomodulatory features [6, 7] . Most plant peptides are linear, smaller than 10 kDa, rich in cysteine, cationic, and partially hydrophobic [8] . These peptides are further divided into the following subfamilies: defensins [9] , thionins [10] , lipid transfer proteins (LTPs) [11] , cyclotides [2] , hevein-like peptides [2] , maize basic peptide-1 (MBP-1) [12] , 2 S albumin-like peptides [2] , and small proteinase inhibitors [13, 14] . Proteinase inhibitors (PIs) are molecules that inhibit the proteolytic activity of proteases by binding and blocking the active site. PIs have been considered as defense molecules which can directly be used against pathogens and invading organisms [15] .
Recently, especially among plant isolates, PIs that concomitantly inactivate specific proteinases with antimicrobial activity have attracted the attention of many researchers. An antimicrobial peptide with inhibitory activity, named FtAMP, was found in the transcriptome data of tartary buckwheat [Fagopyrum tataricum (L.) Gaertn] seeds. FtAMP is highly homologous to BWI-2c in common buckwheat [16] .
In this study, we analyzed the key residues in the reactive loop, which greatly influence the specificity of FtAMP. Site-directed mutagenesis and antimicrobial assays were performed to investigate the relationship between the antimicrobial and inhibitory activities of FtAMP.
Material and Methods

Materials
Isopropyl-β-D-thiogalactopyranoside (IPTG), ampicillin, gene synthesis and PCR primers were purchased from Sangon Biotech (Shanghai, China). T4 DNA ligase and DNA restriction enzymes (NotI and BamHI) were purchased from Thermo Fisher Scientific (Waltham, USA). MutanBEST kit was purchased from TaKaRa (Dalian, China). Trypsin 1:250 (CAS: 9002-07-7), α-chymotrypsin (CAS: 9004-07-3) and elastase (CAS: 39445-21-1) were purchased from Solarbio Life Sciences (Beijing, China). Nα-benzoyl-DL-arginine p-nitroanilide (MFCD00012846), N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (MFCD00077161), and N-succinyl-Ala-Ala-Pro-Leu p-nitroanilide (MFCD00077159) were obtained from Sigma Aldrich (St Louis, USA cDNA cloning and sequence analysis Total RNA was extracted from immature tartary buckwheat seeds and cDNA synthesis was carried out using Superscript Reverse Transcriptase III (Invitrogen, Carlsbad, USA) and 2 μg of DNAsetreated total RNA as recommended by the manufacturer. Based on the immature tartary buckwheat transcriptome database constructed by our laboratory (data not shown), RT-PCR was carried out using gene-specific primers of FtAMP (Supplementary Table S1 ). The sequence was optimized according to the codon preference of E. coli (Supplementary Table S1 ). The optimized sequence was artificially synthesized and then cloned into pUC-18 vector. The following primers were used to construct the prokaryotic expression vector: sense: 5′-ATATGGATCCTCCGAGAAACCGCAACAGGAACT-3′; and antisense: 5′-AATGCGGCCGCTTATCAGCGCTGCTGACGTTCGAA-3′. Primers contained BamHI and NotI restriction sites, respectively. The PCR product was purified and cloned into a pGEM-T easy vector using a pGEM-T cloning kit (Promega) according to manufacturer's instructions. Positive clones were selected and verified by restriction digestion and the product was further verified by DNA sequencing (Sangon Biotech). Primary peptide sequence analysis was performed using bioinformatics programs ProtParam (ExPASy Proteomics Server: http://www.expasy.org/tools/protparam.html). The three-dimensional structure was predicted online using SWISS-MODEL (https://www. swissmodel.expasy.org/) [17] .
FtAMP expression and purification
E. coli BL21 (DE3) pLysS competent cells transformed with the resulting vector pGEX-4T-1-FtAMP were cultured at 37°C in LuriaBertani (LB) medium. A single colony of transformed E. coli BL21 (DE3) pLysS containing a high copy number of the integrated plasmid was inoculated into 5 ml of LB medium and grown at 37°C with shaking at 200 rpm for about 5-6 h, and then transfer to 1000 ml LB medium until A 600 reached 0.6 to generate cell biomass (shaking at 200 g for about 4 h). The culture was replenished with IPTG to a final concentration of 0.2 mM to maintain induction at 16°C overnight (about 12 h). Subsequently, cells were harvested and analyzed for the expression of recombinant protein using SDS-PAGE (12.5% separation gel).
Various parameters such as the induction concentration and time were optimized for maximum expression of FtAMP. Aliquots of culture precipitations isolated under different conditions as well as at different time points were analyzed by SDS-PAGE (12.5% separation gel) for the detection of the fusion protein (GST-FtAMP). FtAMP was expressed as a fusion protein with a GST-Tag (GSTFtAMP) and purified on a GSTrap TM FF column according to manufacturer's instructions. The fusion protein was then concentrated using Millipore Amicon Ultra-15 Centrifugal Filters and carried out using Disposable PD-10 Desalting columns. The GST-tag was cleaved by thrombin (10 unit per mg of fusion protein, for 16 h at 4°C), and again through GSTrap TM FF columns. Protein concentration was determined using a Bradford assay [18] with bovine serum albumin as a standard. SDS-PAGE (15% separation gel plus 36% urea) was used to analyze the purity and apparent molecular weight of the target peptides. The molecular weight was further confirmed by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The peptides were stored at −80°C before structural and antimicrobial assessments.
FtAMP inhibitory site mutation
According to sequence alignment of amino acid deduced from nucleotide sequences of FtAMP and other plant antimicrobial peptides reported in the existing gene databases, a trypsin inhibitor with high homology to FtAMP was found. The FtAMP inhibitory loop (five amino acids), which contains a P1-P1' peptide bond (Arg 21 -Trp 22 ) responsible for directly binding to the enzyme active site to cleave FtAMP was then predicted. It can be speculated that Arg-21 is the functionally important residue in FtAMP. To determine the specific inhibition of FtAMP against trypsin, Arg-21 was mutated to alanine and phenylalanine using the TaKaRa MutanBEST kit. Using the constructed vector pGEX-4T-1-FtAMP as a template, target genes with the mutation site and the site of mutation were amplified by PCR with forward primers 5′-CGTATGAAATTCTGGTCTACC-3′ and 5′-CGTATGAAAGCCTGGTCTACC-3′ for FtAMP-R21F and FtAMP-R21A mutation, respectively, and reverse primer 5′-TTTCA TACGA CAAACGTTCTGA-3′ for both. PCR products were connected to itself (cyclization reaction) using the efficient connection kit and transformed into E. coli DH5α cells, and screened the recombinant plasmids (pGEX-4T-1-FtAMP-R21A and pGEX-4T-1-FtA MP-R21F). In-Fusion cloned products were confirmed by DNA sequence analyzes. Expression and purification methods of the mutants were performed as mentioned above.
Proteases inhibition assay
The inhibitory activity of FtAMP or mutational FtAMP toward different proteases, including bovine trypsin, α-chymotrypsin, and elastase from human leukocytes, were measured spectrophotometrically as previously reported [19] . The following specific chromogenic substrates were used: Nα-benzoyl-DL-arginine p-nitroanilide (BApNA) for trypsin, N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide for α-chymotrypsin, and N-succinyl-Ala-Ala-Pro-Leu p-nitroanilide for elastase. The inhibitory activity of FtAMP was determined by the hydrolysis rate of substrate BApNA. In 4.4 ml of the assay system (100 mM Tris-HCl, pH 8.0, containing 10 mM CaCl 2 ), trypsin was dissolved in 1 mM HCl to a final concentration of 1 mg/ml, and enzymes (20 μl) were incubated for 10 min at 37°C in the presence of various concentrations of FtAMP (30 μl). A total of 20 μl of 150 mM BApNA was then rapidly added and incubated for 10 min.
Reactions were terminated by adding 0.5 ml of 33% acetic acid stop solution and kinetics of p-nitroaniline (PNA) release were measured at 410 nm. The activity of the control sample in the absence of FtAMP was taken as 100% [20] . One unit of inhibitory activity was defined as a decrease of 0.01 per ml reactive fluid per min at 37°C. The inhibition constant for FtAMP against trypsin was calculated following a conventional method. Data are representative of three independent experiments. According to the central structural characteristics of the serine protease family, elastase and α-chymotrypsin were used to identify the inhibitory activity of FtAMP-R21A and FtAMP-R21F using the above method. FtAMP is a competitive inhibitor of trypsin, and the Ki was calculated by the formula as follows [21] :
where K i is the inhibitor's dissociation constant and [I] is the inhibitor concentration; K m is the amount of substrate needed to reach half of the V max ; and K m app , the substrate concentration that is needed to reach V max/2 , increases with the presence of a competitive inhibitor.
Antibacterial assay
The antibacterial activity of peptide was determined in gram-positive bacteria including S. aureus (BNCC 186335) and B. subtilis (BNCC 124990), as well as in gram-negative bacteria, E. coli. (BNCC 337271). Minimum inhibitory concentration (MIC) of the peptides was measured using a modified version of the National Committee for Clinical Laboratory Standards (NCCLS) broth microdilution method [22] . Briefly, the bacterial strains were inoculated and grown to midlog phase in fresh LB broth at 37°C. Bacterial inoculum suspensions were prepared at a final concentration of approximately 10 5 CFU/ml.
Peptides were 2-fold serially diluted to make different concentrations from 0.5 to 256 μM. Equal volumes of inoculum suspensions were then added to each well of a sterile 96-well plate with different peptide concentrations and incubated for 24 h at 37°C. Cultures with or without bacteria were employed as the positive or negative control, respectively. The MIC was defined as the lowest peptide concentration that prevented visible turbidity by visual inspection. Experiments were performed in triplicate with three biological replicates.
Antifungal assay
The antifungal activity of FtAMP was measured using the Oxford cup method. F. oxysporum (BNCC 164775), Rhizopus sp. (BNCC 147803), and T. koningii (BNCC 189731) were used to detect the inhibition of fungal growth. Briefly, fungi were grown on 1.2% potato dextrose agar (PDA) in 90 mm plates for 2-3 days at 28°C. When the diameter of colonies was grown to 1-2 cm, an Oxford cup was placed in the colony periphery. Then, 0.1 ml of 50 μM FtAMP in 20 mM Tris-HCl buffer, pH 8.0 (filtrated through a 0.22 μm membrane) was added to the cup. PDA tablet pre-diffusion was done at 4°C for 12 h and the medium was transferred to a 28°C incubated for 24 h, followed by the observation of colony growth. The antifungal activity of FtAMP-R21A and FtAMP-R21F was also assessed using the same method. The MICs of the peptides against Fungi were further determined in RPMI 1640 medium by a 2-fold microdilution assay [22] . Briefly, fungal strains were cultured on PDA plates at 28°C to prepare mycelium suspensions with a turbidity of a 0.5 McFarland standard. A total of 50 μl inoculum cell suspension diluted in RPMI 1640 medium was added to an equal volume of peptide solution to achieve a final peptide concentrations ranging from 0.25 to 256 μM in a 96-well plate. Pure medium alone or with inoculum suspensions was used as the negative control or the positive control, respectively. The plate was incubated at 28°C for 48 h and colony growth was observed by naked eyes. Experiments were performed in triplicate with three biological replicates.
Statistical analysis
Under the same conditions, antibacterial experiments were performed using the method described above. Subsequently, the antimicrobial activities of FtAMP, FtAMP-R21A, and FtAMP-R21F were compared and the relationship between the active site of FtAMP and antimicrobial activity was measured. The data were presented as the mean ± standard deviation (SD) of experiments conducted in triplicate. Significance of differences was determined by Student's t-test. *P < 0.05, **P < 0.01, ***P < 0.001 versus respective controls.
Results
Structure of FtAMP
The amino acid sequence of FtAMP was derived from its DNA sequence and determined to be GSSEKPQQELEECQNVCRMKRW STEMVHRCEKKCEEKFERQQR. FtAMP is made up of 43 amino acid residues with a theoretical molecular weight of 5330 Da and an isoelectric point of 7.87 ( Table 1) . FtAMP shares high levels of homology with BWI-2c extracted from the common buckwheat (Fagopyrum esculentum Moench); however, the N-terminal of FtAMP contains two additional amino acids, glycine and serine [16] . The 3D structure of the FtAMP was generated by means of homology modeling with the Swiss Model prediction (PDB ID: 2LQX) [16] . A ribbon representation of the FtAMP 3D structure (Fig. 1) shows that the peptide contains two α-helices (Gln 8 -Met 18 and Thr 24 -Glu 36 ) as well as two disulfide bridges to stabilize the structure (Cys 13 -Cys 34 and Cys 17 -Cys 30 ). A random coil conformation (Met 19 -Ser 23 ) at the central loop is the active region, which is located on the surface of the inhibitor and is exposed to the target enzyme. The 5-amino acid active region contains a P1-P1' peptide bond (Arg 21 -Trp 22 ), which allows the inhibitor to specifically bind to the target enzyme and exert its biological function. The structure of FtAMP mutants is similar to that of FtAMP (Fig. 1) , and only the amino acid at P1 was mutated to explore the functional importance of this site.
Expression and purification of peptides
The pGEX-4T-1 plasmid was chosen as the expression vector because N-terminal amino acids of the cleaved target peptide from the fusion protein by thrombin were glycine and serine. The recombinant peptide was completely identical to the natural peptide. The FtAMP DNA sequence was cloned into the pGEX-4T-1 vector and the resulting plasmid pGEX-4T-1-FtAMP was used to transform E. coli BL21 (DE3) pLysS cells. GST-FtAMP was only observed in whole cell lysate supernatant of induced E. coli (Fig. 2A) . The protein was treated with thrombin and purified using a GSTrap TM FF column to obtain a band at the expected size (<14.4 kDa) of FtAMP ( Fig. 2A) . Because the expressed fusion protein contains GST-Tag, it exerts no inhibitory activity against proteinases. Therefore, the specific activity and purification fold could not be calculated. The purification of peptides from the bacterium suspension (1000 ml) is summarized in Table 2 , and the yield of purified FtAMP was 0.55 mg/l. The molecular mass of the FtAMP determined by MALDI-TOF-MS was 5316.7 Da (Supplementary Fig. S1 ).
For the maximum expression of FtAMP, parameters such as inducer concentration and time course were optimized. Time kinetic analysis of FtAMP expression following induction clearly indicated that expression could be detected as early as 4 h after induction. An increase of expression was observed at 0.1-0.2 mM IPTG and slightly lower expression was observed with further increases of IPTG concentration. To produce FtAMP-R21A and FtAMP-R21F, the same general approach was adopted (Fig. 2B) . The yield of purified FtAMP-R21A and FtAMP-R21F was 0.65 and 0.45 mg/l, respectively ( Table 2 ). The molecular mass of FtAMP-R21A and FtAMP-R21F determined by MALDI-TOF-MS were 5231.9 and 5308.0 Da, respectively ( Supplementary Fig. S1 ).
Arg-21 is the inhibitory site of FtAMP as trypsin inhibitor
When FtAMP is present as a fusion protein (GST-FtAMP), it exerts no inhibitory activity against trypsin (Fig. 3A) ; however, when the GST-tag was removed, the purified FtAMP showed inhibitory effects. This indicated that FtAMP with biological activity was successfully purified. Following kinetic analysis, a dose-dependent increase in the inhibition of trypsin activity was observed following a 10-min incubation with different concentrations of FtAMP (Fig. 3B) . The inhibition constant (K i ) for trypsin is 1.90 × 10 −9 M.
Based on the theories of principal specificity of protease and protease inhibitors, two mutants (FtAMP-R21A and FtAMP-R21F) were produced by site-directed mutagenesis. In the trypsininhibitory activity assay, the inhibitory activity of these two mutants, FtAMP-R21A and FtAMP-R21F, was only 17.3% and 14.7% of that of the wild-type FtAMP (Fig. 4) , suggesting that The mean hydrophobicity (H) was calculated using CCS scale as the total hydrophobicity per residue of the peptides. The results of the inhibitory activity of the mutants showed that both FtAMP-R21A and FtAMP-R21F lost their inhibitory activity toward trypsin. According to the central structural characteristics of the serine protease family [23, 25] , elastase and α-chymotrypsin were used to interact with FtAMP-R21A and FtAMP-R21F in order to identify the inhibitory activity of the two mutants. FtAMP-R21A and FtAMP-R21F showed inhibitory effects on elastase and α-chymotrypsin, respectively, whereas wild-type FtAMP had no inhibitory activity against either protease (Fig. 4) . These results showed that mutations in the FtAMP inhibitory site may produce inhibitors with novel activity. Kinetic analysis results showed that the K i of FtAMP-R21A for elastase is 2.47 × 10 −9 M and K i of FtAMP-R21F for α-chymotrypsin is 2.73 × 10 −9 M, respectively.
FtAMP exhibits antimicrobial activity
The antimicrobial activities of the parental peptide and mutants were summarized in Table 3 . AMPs from different sources are known to exhibit broad-spectrum antimicrobial activity. However, this study found that FtAMP showed no obvious inhibitory effects on S. aureus, E. coli., and B. subtilis. Determination of the MIC value ( Table 3 ) and Oxford cup assays revealed that high concentration (128 μM) FtAMP exhibited significant antibacterial ability (Fig. 5A) , and similarly effects were observed in FtAMP-R21A and FtAMP-R21F (Fig. 5B) .
In addition, the antifungal activity of FtAMP was evaluated against T. koningii, Rhizopus sp., and F. oxysporum. In order to understand whether antifungal activity is retained after FtAMP Arg-21 mutation, the inhibitory efficiency against fungi was tested. The growth of three strains of fungi was significantly inhibited following treatment with the peptides (Fig. 6) . For F. oxysporum, AMPs can form a chord-like inhibitory zone on the edge of the mycelium. For Rhizopus sp. and T. koningii, the mycelium continued to spread around the inhibitory area. The colony of the inhibitory area formed a similar inhibition zone, while the colony edge of the control group formed a regular circle, showing no growth inhibition. Therefore, FtAMP, FtAMP-R21A, and FtAMP-R21F inhibited the growth of T. koningii, Rhizopus sp., and F. oxysporum. The mutations in FtAMP inhibitory site did not affect its antifungal activity. The inhibitory activity is concentration-dependent until 128 μM, after which the activity almost plateaued. FtAMP brought about approximately 99% growth inhibition at a concentration of 128 μM. The MIC values of the peptides for T. koningii, Rhizopus sp., and F. oxysporum were determined to be 8 μM, 8 μM, and 16 μM ( Table 3) .
Discussion
In recent years, as incidences of antibiotic-resistant bacteria increase worldwide, the need to develop novel classes of antimicrobial compounds to fight infectious diseases also increases. AMPs have been introduced as a novel class of antifungal agents which has been demonstrated to kill gram-negative and gram-positive bacteria, enveloped viruses, fungi as well as transformed or cancerous cells [26, 27] . For many of these peptides, membrane destruction is considered to be the primary mechanism of cell death and this unique mode of action may reduce the occurrence of bacterial resistance [28] . Several proteinase inhibitors have been reported in common buckwheat [29] [30] [31] [32] and tartary buckwheat [33] . The existence of multiple inhibitor isoforms was mainly attributed to the posttranslational modification of the primary gene product which occurs during seed development. The trypsin inhibitor FtTI is isolated from tartary buckwheat seeds, which has two isoforms (Mr: 11.487 and 13.838 kDa). Analysis of the amino acid sequence suggests that FtTI is a member of the protease inhibitor I family [33] . Furthermore, FtTI strongly inhibits phytopathogenic fungi strains, including Mycosphaerella melonis, Alternaria cucumerina, Alternaria solani, Colletotrichum gloeosporioides and Phytophthora capsici [34] . Most previous studies have revealed that natural amphiphilic AMPs have flexible random structures in aqueous solutions and fold into α-helical structures in membrane simulation environments [34] . Significant similarity is found between FtAMP and another trypsin inhibitor from Fagopyrum esculentum (common buckwheat) known as BWI-2c [16] or from Capsicum baccatum L. known as vicilin-like antimicrobial peptides 2-2 [35] . Both inhibitors share similar helixloop-helix motifs [16, 36] . The primary structure signature of α-hairpinins family inhibitors is C 1 X 3 C 2 XnC 3 X 3 C 4 (where X stands for any residue) and members share low sequence homology, but contain the motif CXXXC in two antiparallel α-helices and four cysteine residues engaged in two disulfide bridges with the connectivity C 1 -C 4 and C 2 -C
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. Two antiparallel α-helices are joined by a central loop and stapled by S-S-bonds [37] [38] [39] [40] . The amino acid residues in the reactive loop may affect the property of peptides as an inhibitor, and the crucial basic residues in the loop may mediate its interaction with trypsin. When the basic residue is lost, the peptide shows no inhibitory activity against trypsin, as observed in the antifungal peptide EcAMP1 from barnyard grass [41] . It is also believed that this loop is flexible and that when basic residue is the first or last amino acid in the loop, the peptide may also have no inhibitory activity against trypsin as seen in SM-AMP-X from Stellaria media seeds [42] . However, all these peptides show antimicrobial activity no matter whether they possess inhibitory activity against trypsin or other proteases. The truncation of the polypeptide chain of SM-AMP-X in the N-and C-terminal regions is accompanied by a loss of α-helical structure and antifungal activity [42] , indicating that the N-and C-terminal regions contribute to the antifungal activity of the peptide either directly or through the stabilization of its helical structure. Remarkably, it is possible that other members of the α-hairpinin family have antibacterial activity, but only SmAMP3, MiAMP2d [43] and MBP-1 have been challenged against bacteria until now in the literature. The FtAMP in this study also showed strong antifungal activity, but only showed weak antibacterial activity at high concentrations. 37°C prior to addition of the substrate (30 μl). Control (100%) is the activity of specific binding with proteases. Protease was not incubated with the peptides against corresponding substrate reaction. The three groups were as follows: BANPA for trypsin; N-succinyl-Ala-Ala-Pro-Leu p-nitroanilide for elastase; N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide for α-chymotrypsin. The data were shown as the mean ± SD of experiments conducted in triplicate. *P < 0.05, **P < 0.01, ***P < 0.001 versus respective controls. Similarly, it is generally believed that the principal specificity of protein inhibitors is dependent on the character of the side-chain of the P1 position. Shape complementarity of interacting areas together with P1-P1' hydrogen bonds ensure very similar recognition of different proteases and inhibitors [23] . Trypsin hydrolyzes the peptide bond right after basic residues (Arg/Lys) at the P1 position of the substrate or inhibitor, chymotrypsin will cleave the peptide bond right after large hydrophobic residues (Tyr/Trp/Phe), and elastase hydrolyzes the peptide bond right after aliphatic residues (Val/Leu/ Ser/Ala) [24] . Our results showed that, upon mutation of the basic amino acids, these peptides lost their inhibitory activity. By mutation within the inhibitory site, these peptides can be converted into novel inhibitors. Our predictive results indicated that the secondary structure of FtAMP and FtAMP-mutants exhibit the same α-helical conformational features with no changes in their antifungal activity. Arg-21 was identified as the active site of FtAMP according to sequence homology comparison and theoretical prediction. The FtAMP-R21A and FtAMP-R21F mutants were obtained by sitedirected mutagenesis of Arg-21 in FtAMP (Fig. 4) . Protease inhibition assays showed that both FtAMP-R21A and FtAMP-R21F lost their inhibitory effects toward trypsin (Fig. 4) . FtAMP showed no activity against the serine proteases α-chymotrypsin and elastase, indicating the high selectivity of FtAMP (Fig. 4) . These data suggest that FtAMP and its mutants have a high affinity for the corresponding proteases and specifically bind to the enzyme activity site at certain concentrations. Moreover, this resulted in a loss of their catalytic activity and illustrated the high selectivity of the inhibitor. Therefore, FtAMP may be specific toward trypsin proteases. Meanwhile, two new protease inhibitors were acquired. These results were consistent with the above conjecture and showed that FtAMP may provide a novel scaffold for the design of new protease inhibitors.
Consequently, changes of the inhibitory site of FtAMP had no effect on its antimicrobial activity. Most previously reported general antimicrobial peptides have no trypsin inhibitor activity [26] , indicating that FtAMP is a bifunctional polypeptide that can function as both an antibacterial peptide and a trypsin inhibitor. These results also suggest that the antimicrobial activity has no direct connection with the loop in α-hairpinins peptides. Rather, it may be related to α-helices, especially the amino acid composition, charge and amphiphilicity of these α-helices. The antimicrobial activity of FtAMP is attributed to the two α-helices in the N-and C-terminal regions. Thus, α-helices of the molecule are crucial for FtAMP antifungal activity. Whether the helices carry antimicrobial determinants or are vital for α-helix formation that in turn results in specific antimicrobial activity remains to be further explored. In addition, some peptides also exhibit ribosome-inactivating activity [44] . However, their common structural features have not been thoroughly explored.
The results showed that the antimicrobial activity of FtAMP is related to α-helix structure. Helical wheel projection analysis showed that polar and non-polar face is significant, and these belong to typical amphipathic α-helix AMPs. Amphipathic α-helical AMPs usually have excellent broad-spectrum antimicrobial activity, which is interesting that FtAMP has weak antibacterial activity. Initially, Figure 5 . Antibacterial activity of the peptides (A) MIC of FtAMP against bacteria was determined as the lowest peptide concentration that inhibited bacteria growth. (B) Antibacterial activity of the peptides. Control did not contain peptides. Compared with control group, 128 μM FtAMP has significant antibacterial ability (P < 0.05), Values were shown as the mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus respective controls. CON, control. Rhizopus sp., and (C) Trichoderma koningii. Fungal spores were incubated with sterile water (control) and different concentrations of the peptides (1, 32 μM; 2, 64 μM). Growth inhibition was measured after 12 h of incubation at 28°C. Data were shown as the mean ± SD of experiments conducted in triplicate. MIC values against T. koningii, Rhizopus sp., and F. oxysporum were determined to be 8 μM, 8 μM, and 16 μM, respectively. CON, control.
we speculated that it is because of the positively charged residues in the center of non-polar faces. Therefore, the relationship between the protein structure and function needs to be further investigated [45] .
In summary, FtAMP was expressed via genetic engineering and the inhibitory site of FtAMP was examined as a trypsin inhibitor. Furthermore, two mutants were obtained through site-directed mutagenesis. Activity analysis revealed that Arg-21 is the specific inhibitory site for FtAMP activity against trypsin. At the same time, two new protease inhibitors were obtained. Antimicrobial assays showed that these peptides exhibit strong antifungal activity against T. koningii, Rhizopus sp. and F. oxysporum. These findings suggested that the changes of FtAMP inhibitory site had no effect on its antifungal activity. In conclusion, the product of FtAMP modification has the potential to be a promising antifungal agent.
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